Literature DB >> 33626255

β-Thalassemias.

Ali T Taher1, Khaled M Musallam1, M Domenica Cappellini1.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 33626255     DOI： 10.1056/NEJMra2021838

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

1.  Does size matter? Two new deletions in the HBB gene cause β0-thalassemia.

Authors:  Paloma Ropero; Fernando Ataúlfo González Fernández; Jorge M Nieto; Valle Recasens; Ángeles Montañés; María José Murúzabal; María Sarasa; Cristina Fernández; Ana Villegas; Cuesta C Benavente
Journal:  Ann Hematol       Date:  2022-04-25       Impact factor: 3.673

2.  Activation of γ-globin expression by hypoxia-inducible factor 1α.

Authors:  Ruopeng Feng; Thiyagaraj Mayuranathan; Peng Huang; Phillip A Doerfler; Yichao Li; Yu Yao; Jingjing Zhang; Lance E Palmer; Kalin Mayberry; Georgios E Christakopoulos; Peng Xu; Chunliang Li; Yong Cheng; Gerd A Blobel; M Celeste Simon; Mitchell J Weiss
Journal:  Nature       Date:  2022-10-12       Impact factor: 69.504

3.  A spectrum of recessiveness among Mendelian disease variants in UK Biobank.

Authors:  Alison R Barton; Margaux L A Hujoel; Ronen E Mukamel; Maxwell A Sherman; Po-Ru Loh
Journal:  Am J Hum Genet       Date:  2022-05-31       Impact factor: 11.043

Review 4.  Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Authors:  Annamaria Aprile; Silvia Sighinolfi; Laura Raggi; Giuliana Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-11

5.  Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies.

Authors:  Boya Liu; Christian Brendel; Divya S Vinjamur; Yu Zhou; Chad Harris; Meaghan McGuinness; John P Manis; Daniel E Bauer; Haiming Xu; David A Williams
Journal:  Mol Ther       Date:  2022-05-06       Impact factor: 12.910

Review 6.  Advancing the care of β-thalassaemia patients with novel therapies.

Authors:  Rayan Bou-Fakhredin; Irene Motta; Maria Domenica Cappellini
Journal:  Blood Transfus       Date:  2021-10-21       Impact factor: 3.443

7.  SARS-CoV-2 infection in patients with β-thalassemia: Experience from Lebanon.

Authors:  Rayan Bou-Fakhredin; Hisham Daadaa; Suzanne Koussa; Therese Abou Nasr; Peter Noun; Ali T Taher
Journal:  Am J Hematol       Date:  2021-05-13       Impact factor: 13.265

8.  Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis.

Authors:  Hongxia Yan; Abdullah Ali; Lionel Blanc; Anupama Narla; Joseph M Lane; Erjing Gao; Julien Papoin; John Hale; Christopher D Hillyer; Naomi Taylor; Patrick G Gallagher; Azra Raza; Sandrina Kinet; Narla Mohandas
Journal:  Am J Hematol       Date:  2021-06-03       Impact factor: 13.265

Review 9.  EnvIRONmental Aspects in Myelodysplastic Syndrome.

Authors:  Verena Petzer; Igor Theurl; Günter Weiss; Dominik Wolf
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.

Authors:  Anuraag R Kansal; Odette S Reifsnider; Sarah B Brand; Neil Hawkins; Anna Coughlan; Shujun Li; Lael Cragin; Clark Paramore; Andrew C Dietz; J Jaime Caro
Journal:  J Mark Access Health Policy       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.